about
Interleukin-1 alpha has antiallodynic and antihyperalgesic activities in a rat neuropathic pain modelOpioid-dependent regulation of high and low fear responses in two inbred mouse strains.Regulation of ERK1/2 phosphorylation by acute and chronic morphine - implications for the role of cAMP-responsive element binding factor (CREB)-dependent and Ets-like protein-1 (Elk-1)-dependent transcription; small interfering RNA-based strategy.Morphine activates Arc expression in the mouse striatum and in mouse neuroblastoma Neuro2A MOR1A cells expressing mu-opioid receptors.Activation of AP-1 and CRE-dependent gene expression via mu-opioid receptor.Differential activation of spinal microglial and astroglial cells in a mouse model of peripheral neuropathic pain.Regulation of kinesin light chain 1 level correlates with the development of morphine reward in the mouse brain.Behavioral and transcriptional patterns of protracted opioid self-administration in mice.Regulation of the extracellular signal-regulated kinases following acute and chronic opioid treatment.Attenuation of morphine tolerance by minocycline and pentoxifylline in naive and neuropathic mice.Regulation of alpha-synuclein expression in limbic and motor brain regions of morphine-treated mice.Behavioral and molecular alterations in mice resulting from chronic treatment with dexamethasone: relevance to depression.alpha-Synuclein expression in the brain and blood during abstinence from chronic alcohol drinking in mice.Neurochemical and Neurotoxic Effects of MDMA (Ecstasy) and Caffeine After Chronic Combined Administration in Mice.Alterations in the Activity of Spinal and Thalamic Opioid Systems in a Mice Neuropathic Pain ModelGlucocorticoid receptor signaling in astrocytes is required for aversive memory formationEffects of Glycogen Synthase Kinase 3beta and Cyclin-Dependent Kinase 5 Inhibitors on Morphine-Induced Analgesia and Tolerance in RatsInfluence of behavioral traits in the inter-individual variability of nociceptive, emotional and cognitive manifestations of neuropathic pain.Neuropathic Pain Dysregulates Gene Expression of the Forebrain Opioid and Dopamine Systems
P50
Q28571428-2E5C45FD-FEFF-4958-B14C-E6347C9C33C7Q39278021-E83468E1-E5F9-488B-9B99-A215AEE6B1E5Q39963045-F568B9B6-4B44-46CF-83C6-C6776B12FBEFQ40364422-F09D71AA-D25E-45C8-9037-F9783524F403Q40529690-8A7C9A44-35E7-4458-9F59-FF13FF17F535Q43274323-5FDF69F0-406E-47F4-9C36-DD79823D1384Q43280025-1559CBC7-2170-4505-A895-5B4A12CA0ED6Q44339836-46BC6AD7-418C-458F-B9F0-017A50D07412Q44350356-76127DAF-086F-44DD-B139-1C49C478B56FQ46442655-2EB5EDC0-91C6-429D-8B46-EEF12C952EE9Q46497170-31B36587-370F-4DDC-BA6B-4831CF205DCDQ46600443-ED6B1827-21AF-4955-AA4B-01AD8FD464C8Q46612185-D3C8EB7F-3AFC-4ED9-B1CE-0D69D647B69BQ47602688-5F3A911E-7E56-4D7D-A321-F70066145B7CQ57465340-ECCA73AB-F58E-466A-AA1F-564F8819BCC2Q59806376-6E0B8318-6627-4B02-97EA-3885166FE1E6Q60691205-2568F9BC-00FA-4823-9CBC-42E9161BA440Q67495580-75C27F02-1C05-47F5-A5A0-98CF1B1B31B0Q89566138-6B3065AD-4432-4F6D-A2ED-342551A176F3
P50
description
Polish researcher
@en
Pools onderzoekster
@nl
polska badaczka, w Instytucie Farmakologii PAN w Krakowie
@pl
name
Agnieszka Wawrzczak-Bargiela
@ast
Agnieszka Wawrzczak-Bargiela
@es
Agnieszka Wawrzczak-Bargiela
@nl
Agnieszka Wawrzczak-Bargiela
@sl
Agnieszka Wawrzczak-Bargieła
@en
Agnieszka Wawrzczak-Bargieła
@ga
Agnieszka Wawrzczak-Bargieła
@pl
type
label
Agnieszka Wawrzczak-Bargiela
@ast
Agnieszka Wawrzczak-Bargiela
@es
Agnieszka Wawrzczak-Bargiela
@nl
Agnieszka Wawrzczak-Bargiela
@sl
Agnieszka Wawrzczak-Bargieła
@en
Agnieszka Wawrzczak-Bargieła
@ga
Agnieszka Wawrzczak-Bargieła
@pl
altLabel
Agnieszka Wawrzczak-Bargiela
@en
prefLabel
Agnieszka Wawrzczak-Bargiela
@ast
Agnieszka Wawrzczak-Bargiela
@es
Agnieszka Wawrzczak-Bargiela
@nl
Agnieszka Wawrzczak-Bargiela
@sl
Agnieszka Wawrzczak-Bargieła
@en
Agnieszka Wawrzczak-Bargieła
@ga
Agnieszka Wawrzczak-Bargieła
@pl
P106
P1153
8362592700
P1412
P21
P27
P31
P496
0000-0002-9051-8369